HbH disease due to compound heterozygosity for hemoglobins Zürich‐Albisrieden and Sallanches-Reference-Cited by-同舟云学术

HbH disease due to compound heterozygosity for hemoglobins Zürich‐Albisrieden and Sallanches

Published:2020-01-13 Issue:4 Volume:67 Page:
ISSN:1545-5009
Container-title:Pediatric Blood & Cancer
language:en
Short-container-title:Pediatr Blood Cancer

Author:

Sharma Prashant¹^ORCID,Das Reena¹^ORCID,Khadwal Alka Rani²,Karmakar Indrani¹,Hira Jasbir Kaur¹,Chhabra Sanjeev¹

Affiliation:

1. Department of HematologyPostgraduate Institute of Medical Education & Research Chandigarh India

2. Pediatric‐to‐Adult Crossover ClinicAdult Clinical Hematology UnitDepartment of Internal MedicineNehru HospitalPostgraduate Institute of Medical Education & Research Chandigarh India

Publisher

Wiley

Subject

Oncology,Hematology,Pediatrics, Perinatology, and Child Health

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/pbc.28161

Reference10 articles.

1. Thalassemia major phenotype caused by HB Zürich-Albisrieden [α2 59(E8) Gly > Arg (HBA2:C.178G > C)] in a Brazilian child

2. Cation-exchange high-performance liquid chromatography for variant hemoglobins and HbF/A2: What must hematopathologists know about methodology?

3. A new α chain variant Hb Sallanches [α2 104(G11) Cys→Tyr] associated with HbH disease in one homozygous patient

4. Hb Sallanches [α104(G11)Cys→Tyr, TGC>TAC] Occurs Frequently on the Indian Subcontinent

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Wide spectrum of novel and rare hemoglobin variants in the multi‐ethnic Indian population: A review;International Journal of Laboratory Hematology;2024-03-19

2. Molecular Heterogeneity of Hb H Disease in India;Thalassemia Reports;2022-07-06